INTERVIEW Christophe Nicoli, SGD PHARMA’s, CEO “In our business, we have to go to What preparations had been made tomanage such a crisis?even more strict pharma standards.” As a critical supplier of the pharmaceutical industry, we are used to prepare “contin- gency plans”, and this has been useful. But let’s be honest: no one could imagineWhat impact did the crisis have on the magnitude andthe consequences your organization? of this truly unprecedented crisis. Like many others, we gather every morningThanks to our employees’ efforts, our a C-19 task force and take decisions5 glass plants are stillrunning full ca- to adapt a fast-changing environment.pacity in France, Germany and China. Our plant in Zhanjiang, Southern China,We had to stop one tubular workshop has been the first one concerned. Thein India, where the government has put strong management of the crisis therein place the “lockdown” limiting to 25% (no employee infected so far) has beenof normal headcount, for all industries, a great help to anticipate key actions inbut the situation is improving fast. Our our European plants: masks, temperature,clients themselves are on the frontline workshops and social areas organizationto continue to supply the heath system. to restraint interactions. We work with them very closely to build